2023-08-17 |
2023-08-16 |
S
Sale
|
CARLSON CAPITAL L P
Large shareholder
|
1,000
-0.0%
0.39
USD 392
|
1,000
-0.0%
|
0.39
|
USD 392
|
|
2023-08-17 |
2023-08-15 |
S
Sale
|
CARLSON CAPITAL L P
Large shareholder
|
215,000
-4.1%
0.44
USD 94,041
|
215,000
-4.1%
|
0.44
|
USD 94,041
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
MILLS ROBERT S
Non-Executive Director
|
40,000
+250.3%
0.25
USD 10,000
|
40,000
+250.3%
|
0.25
|
USD 10,000
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
Mikhak Zamaneh
Chief Medical Officer
Officer
|
120,000
+800.0%
0.25
USD 30,000
|
120,000
+800.0%
|
0.25
|
USD 30,000
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
ROCAMBOLI STEPHEN
Non-Executive Director
|
20,000
+125.0%
0.25
USD 5,000
|
20,000
+125.0%
|
0.25
|
USD 5,000
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
COLEMAN KIRK ALLEN
Chief Financial Officer
Officer
|
20,000
+127.6%
0.25
USD 5,000
|
20,000
+127.6%
|
0.25
|
USD 5,000
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
Weisman Harlan F
President and CEO
Executive Director
|
600,000
+279.6%
0.25
USD 150,000
|
600,000
+279.6%
|
0.25
|
USD 150,000
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
Roberts Brandi
Non-Executive Director
|
20,000
+inf%
0.25
USD 5,000
|
20,000
+inf%
|
0.25
|
USD 5,000
|
|
2023-03-13 |
2023-03-10 |
B
Purchase
|
Weisman Harlan F
President and CEO
Executive Director
|
150,000
+232.1%
0.88
USD 131,835
|
150,000
+232.1%
|
0.88
|
USD 131,835
|
|
2023-03-13 |
2023-03-10 |
B
Purchase
|
ROCAMBOLI STEPHEN
Non-Executive Director
|
13,000
+433.3%
0.80
USD 10,433
|
13,000
+433.3%
|
0.80
|
USD 10,433
|
|
2023-03-13 |
2023-03-10 |
B
Purchase
|
Mikhak Zamaneh
Chief Medical Officer
Officer
|
15,000
+inf%
0.82
USD 12,300
|
15,000
+inf%
|
0.82
|
USD 12,300
|
|
2023-03-13 |
2023-03-10 |
B
Purchase
|
COLEMAN KIRK ALLEN
Chief Financial Officer
Officer
|
12,000
+326.5%
0.79
USD 9,457
|
12,000
+326.5%
|
0.79
|
USD 9,457
|
|
2022-12-19 |
2022-12-15 |
B
Purchase
|
Weisman Harlan F
President and CEO
Executive Director
|
50,000
+342.1%
1.06
USD 53,000
|
50,000
+342.1%
|
1.06
|
USD 53,000
|
|
2022-11-23 |
2022-11-22 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
43,470
+43.5%
1.15
USD 49,991
|
43,470
+43.5%
|
1.15
|
USD 49,991
|
|
2022-05-20 |
2022-05-20 |
B
Purchase
|
Weisman Harlan F
Non-Executive Director
|
4,615
+46.2%
5.50
USD 25,383
|
4,615
+46.2%
|
5.50
|
USD 25,383
|
|
2022-05-20 |
2022-05-18 |
B
Purchase
|
Weisman Harlan F
Non-Executive Director
|
2,500
+33.3%
5.12
USD 12,800
|
2,500
+33.3%
|
5.12
|
USD 12,800
|
|
2022-05-17 |
2022-05-17 |
B
Purchase
|
Fletcher Aaron G.L.
Non-Executive Director
|
24,600
+28.9%
5.08
USD 124,968
|
24,600
+28.9%
|
5.08
|
USD 124,968
|
|
2022-05-17 |
2022-05-17 |
B
Purchase
|
COLEMAN KIRK ALLEN
Chief Financial Officer
Officer
|
425
+13.1%
4.83
USD 2,053
|
425
+13.1%
|
4.83
|
USD 2,053
|
|
2022-05-17 |
2022-05-16 |
B
Purchase
|
Mattes Glenn R.
President and CEO
Executive Director
|
16,000
+80.0%
4.78
USD 76,480
|
16,000
+80.0%
|
4.78
|
USD 76,480
|
|
2022-05-17 |
2022-05-16 |
B
Purchase
|
ROCAMBOLI STEPHEN
Non-Executive Director
|
3,000
+19.1%
4.54
USD 13,620
|
3,000
+19.1%
|
4.54
|
USD 13,620
|
|